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Strengths and limitations of this study
 ► This is the first systematic review to evaluate 
whether physical tests can be used to differentiate 
cervicogenic headache from migraine and both con-
ditions from asymptomatic subjects.
 ► The results will provide a clearer understanding of 
the role of the physical assessment of patients with 
cervicogenic headache and migraineurs, including 
which tests are more useful to differentiate between 
the two headache types.
 ► Synthesis of results will follow recommendations 
from the COnsensus- based Standards for the selec-
tion of health Measurement INstruments (COSMIN) 
guideline for systematic reviews and the quality 
of the evidence will be assessed using the Quality 
Assessment of Diagnostic Accuracy Studies and 
Downs and Black checklists.
 ► An initial scoping search suggests that a meta- 
analysis may not be possible due to heterogeneity 
of available data.
ABSTRACT
Introduction Differential diagnosis of migraine and 
cervicogenic headache (CGH) can be challenging given 
the large overlap of symptoms, commonly leading to 
misdiagnosis and ineffective treatment. In order to 
strengthen the differential diagnosis of headache, previous 
studies have evaluated the utility of physical tests to 
examine for musculoskeletal impairment, mainly in the 
cervical spine, which could be provoking or triggering 
headache. However, no systematic review has attempted 
to evaluate whether physical tests can differentiate CGH 
from migraine or both conditions from asymptomatic 
subjects.
Methods/analysis A systematic review protocol has been 
designed and is reported in line with Preferred Reporting 
Items for Systematic Reviews and Meta- Analyses Protocols 
(PRISMA- P). A sensitive topic- based search strategy is 
planned which will include databases, hand searching of key 
journals and consultation of relevant leading authors in this 
field. Terms and keywords will be selected after discussion 
and agreement. Two independent reviewers will perform 
the search and select studies according to inclusion and 
exclusion criteria, including any cohort or observational 
studies evaluating the topic of this review; a third reviewer 
will confirm accuracy. A narrative synthesis will be developed 
for all included studies and, if possible, a meta- analysis 
will be conducted. The overall quality of the evidence will 
be assessed using the Quality Assessment of Diagnostic 
Accuracy Studies (QUADAS-2) checklist for diagnostic 
accuracy studies and the Downs and Black scale for those 
studies where the QUADAS-2 checklist cannot be applied.
Ethics and dissemination Ethical approval is not 
required since no patient information will be collected. 
The results will provide a deeper understanding about 
the possibility of using physical tests to differentiate 
cervicogenic headache from migraine and from 
asymptomatic subjects, which has direct relevance for 
clinicians managing people with headache. The results will 
be published in a peer- reviewed journal and presented at 
scientific conferences.
PROSPERO registration number CRD42019135269.
InTROduCTIOn
Headache is one of the most common disor-
ders throughout the world, with 50% of the 
European population classified as headache 
sufferers. Not surprisingly, headache is associ-
ated with high levels of disability,1 2 poor quality 
of life and reduced labour productivity.3
According to the International Head-
ache Society, headaches can be broadly 
classified as either primary or secondary. 
Primary headaches, such as migraine, are 
headaches not caused by underlying disease 
or structural problems, whereas secondary 
headaches are considered symptoms of an 
underlying and known disorder.4 Cervico-
genic headache (CGH) is an example of a 
secondary headache, and in this case the 
main disorder is a dysfunction within the 
cervical structures, especially the upper 
cervical segments.5 Convergence of cervical 
and trigeminal afferents in the trigemino-
cervical nucleus can potentially explain 
the referred pain perceived as headache 
in patients with CGH.5 However, the 
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convergence of cervical and trigeminal afferents in the 
trigeminocervical nucleus can be bidirectional, and 
could also explain why some migraine or tension type 
headache sufferers perceive neck pain in the absence 
of cervical musculoskeletal dysfunction.6–8 In addition, 
this interaction in the trigeminocervical complex could 
trigger additional pain to the head in migraineurs, when 
central sensitisation develops in the nociceptive trigem-
inocervical system.9–11
The overlap of signs and symptoms between migraine 
and CGH (online supplementary file 1) contribute to 
the difficulty in the differential diagnosis of headache 
types,12 13 which become more complex in case of mixed 
headache presentations.13 Indeed, it has been argued 
that in ~50% of cases, the diagnosis may be incorrect,14 
leading to inappropriate treatment choices.
The diagnostic criteria applied to headache both in 
research and clinical practice, typically adhere to those 
described by the International Classification of Head-
ache Disorders (International Headache Society, IHS)4 
and the criteria proposed by the Cervicogenic Headache 
International Study Group15(CHISG), later re- evaluated 
by Antonaci et al.16 In order to strengthen the differen-
tial diagnosis of headache, some studies have evaluated 
the utility of physical tests to examine for musculoskeletal 
impairments, mainly in the cervical spine, which could be 
provoking or triggering the headache (eg, manual exam-
ination,17 18 mobility tests19–21 or strength evaluation,22 23 
among others).
Two systematic reviews24 25 have attempted to assess 
the usefulness of physical examination and manual 
examination, respectively, for the differential diagnosis 
of CGH, and a further systematic review26 was directed 
at elucidating which examination tests can be useful to 
detect musculoskeletal impairment in migraine sufferers. 
In addition, another systematic review27 assessed diag-
nostic accuracy of headache measurement instruments. 
Although for migraine all of these tools were question-
naires, and the diagnostic accuracy of only one physical 
test was evaluated for CGH. No systematic review has 
attempted to evaluate whether physical tests can differ-
entiate CGH from migraine and both conditions from 
asymptomatic individuals. Thus, the purpose of this 
systematic review will be to determine whether: (1) phys-
ical examination, including manual examination, can 
be used to differentiate people with CGH from asymp-
tomatic individuals, (2) physical examination, including 
manual examination, can be used to differentiate people 
with migraine from asymptomatic individuals and (3) 
physical examination, including manual examination, 
can be used to differentiate people with CGH from those 
with migraine. To achieve these purposes, we will collect 
data about physical examination procedures assessing 
musculoskeletal dysfunction in migraine sufferers, people 
with CGH and asymptomatic subjects. The results of this 
systematic review will have direct relevance for clinicians 
managing people with headache.
METhOdS
The protocol for this systematic review has been designed 
following scoping searches of the available literature 
and is reported in accordance with criteria established 
by Preferred Reporting Items for Systematic Review and 
Meta- Analysis Protocols (PRISMA- P) guidelines (online 
supplementary file 2).28 29
Eligibility criteria
Inclusion criteria
Population
Any study including the physical examination of an 
adult population (>18 years old) suffering from CGH, 
migraine or mixed headaches with possible cervical 
involvement, as defined by the IHS4 and CHISG.15 Studies 
assessing people with a diagnosed cervical pathology will 
be included in this review. Studies, which include other 
headache types such as tension- type headache, will be 
included if data for CGH or migraine are reported inde-
pendently. For the studies assessing diagnostic accuracy 
in CGH, we will accept any diagnosis based on the IHS 
and CHISG with the exception of diagnostic anaesthesic 
blocks. This diagnosis was defined as acceptable if the 
headache was intermittent, side dominant, headache of 
moderate intensity, without side shift and it was required 
to be preceded by ipsilateral neck pain and precipitated 
or aggravated by neck movement or posture, fulfilling five 
out of seven criteria outlined by Antonaci,16 as proposed 
in other studies. In relation to diagnostic accuracy studies 
for migraine, diagnosis must be based on the IHS criteria11 
for migraine without aura. In addition, this diagnosis will 
be considered as acceptable if it does not meet the IHS 
criteria for other forms of headache. Finally, asymptom-
atic subjects will be defined as those people who had no 
history of subjective features of CGH, migraine, migraine 
with aura headache, episodic headache and neck pain or 
stiffness.
Intervention
The intervention of interest is the physical examination 
directed at evaluating the presence or absence of cervical 
musculoskeletal impairment in CGH and/or migraine 
sufferers. This includes studies examining cervical artic-
ular, muscular and/or neural structures.
As described previously,24 physical examination tests are 
defined as clinician performed tests or measures that were 
designed to obtain a diagnosis or detect an impairment.
Comparison
The studies included must compare physical examination 
findings between (a) CGH and asymptomatic controls; 
(b) CGH and migraine; (c) migraine and asymptomatic 
controls and/or (d) CGH, migraine and asymptomatic 
controls.
Outcome measures
Any physical examination or test designed to evaluate 
the musculoskeletal system including, but not limited 
to, range of motion, muscular strength and endurance, 
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reproduction or resolution of symptoms by manual exam-
ination, tenderness palpation, proprioceptive measures.
Study design
Case–control studies will be the study design of refer-
ence for this review. Any cohort study or observational 
study design will also be included. If diagnostic tests 
were performed prior to an intervention, randomised 
controlled trials will be also included. Case studies and 
previous literature reviews including systematic reviews 
and meta- analyses will be excluded.
Measurement properties
Any observational study evaluating one or more measure-
ment property will be included. If possible, data on 
diagnostic accuracy will be collected in this review. For 
diagnostic accuracy, we will collect sensitivity (SN), spec-
ificity (SP), positive and negative likelihood ratios (LR+ 
and LR−) and positive and negative predictive values 
(PPV and NPV). SN is defined as the percentage of people 
who test positive for a specific diagnosis among a group 
of people who have the diagnosis. SP is the percentage of 
people who test negative for a specific diagnosis among 
a group of people who do not have the diagnosis. A LR+ 
identifies the strength of a test in determining the pres-
ence of a finding. A higher LR+ reflects a stronger ability 
to detect the condition when the test is positive. The LR− 
identifies how much the odds of the diagnosis decrease 
when a test is negative. The lower the value, the better the 
ability of the test to determine the chance, the diagnosis 
is actually present in the event the finding is negative.30 
Finally, PPV and NPV are the proportions of individuals 
with positive and negative test results, respectively, who 
are correctly diagnosed.31
Timing and setting
No restriction on setting or timing will be imposed.
Exclusion criteria
People suffering of a serious disease or another diag-
nosed headache condition not described in the inclusion 
criteria will be excluded. Individuals with a history of 
head or neck trauma will also be excluded. In addition, all 
studies which are not written in English will be excluded.
Source of information
The search will include articles from the following 
databases: Medline, PubMed, Web of Science, Scopus, 
EMBASE and CINAHL. Search strategies in these data-
bases will include medical subject headings (MESH) and 
natural language terms. In addition, we will perform hand 
searching of specific journals where we found potentially 
eligible studies in an initial scoping search: Cephalalgia, 
Headache, The Journal of Headache and Pain, Current Pain 
and Headache Reports, Manual Therapy, Musculoskeletal 
Science and Practice, Physical Therapy and Journal of Manipu-
lative and Physiological Therapeutics. This systematic review 
will be conducted between October 2019 and January 
2020.
Search strategy
This search will be completed by two reviewers (EA and 
GFC). An initial MEDLINE search strategy will be defined, 
including MESH keywords and natural language term 
combinations that will be adapted to other databases. The 
specific search strategies will be developed in consensus 
by all authors and facilitated by a health science librarian. 
Search strategy will be developed between 30 September 
2019 and 31 October 2019.
Example of search strategy used in Medline
(((cervicogenic headache [Mesh Term]) OR migraine 
disorder [Mesh Term])) AND ((((((((((((((((((((phys-
ical diagnosis [Mesh Term]) OR physical examination 
[Mesh Term]) OR manual examination [All Fields]) OR 
physical tests [All Fields]) OR cervical musculoskeletal 
impairments [All Fields]) OR endurance[All Fields]) OR 
cranio- cervical flexion [All Fields]) OR muscle function 
[All Fields]) OR flexion- rotation [All Fields]) OR joint 
position error [All Fields]) OR joint position sense [All 
Fields] OR tenderness [All Fields]) OR trigger point 
[All Fields]) OR joint [All Fields]) OR mobility [All 
Fields]) OR range of motion [All Fields]) OR pressure 
pain threshold [All Fields]) OR posture [All Fields]) OR 
muscle strength [All Fields]))
Results of the search and the process of screening 
and selecting studies for inclusion in the review will be 
presented in a flow diagram described by PRISMA- P 
guidelines.27 28
data management
All results will be uploaded and stored on Mendeley, a 
desktop and web programme. Any duplicates will be iden-
tified and removed. Each reviewer will save the results in 
an individual folder.
Study selection
Two reviewers (EA and GFC) will independently screen 
titles/abstracts against the prespecified inclusion/exclu-
sion criteria and subcategorise into include/exclude/
unsure. For those that meet the inclusion criteria, the 
full texts will be obtained. Moreover, if any uncertainty 
exists, then the full text will be retrieved for further clar-
ification. If needed, the authors of the original work will 
be contacted. Screening of full texts will be conducted 
in the same manner using the predefined criteria and 
conducted independently.
Articles will be included when eligibility is confirmed 
by both reviewers. Any disagreement between the two 
reviewers will be first discussed in a consensus meeting 
between the reviewers, and if no agreement can be 
made, an independent reviewer (KL) will be sought to 
decide about inclusion. Information on excluded studies 
and reasons for exclusion will be collated and reported. 
Reviewers will not be blinded to journal titles and study 
authors.
data collection and data items
A standardised form will be used to extract informa-
tion from the included studies. Both reviewers will 
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independently extract information, with one reviewer 
subsequently collating the information. Any disagree-
ments between the reviewers will be discussed and/or 
reviewed by a third reviewer.
Data extracted will include the following summary data: 
title and authors, year of publication, sample character-
istics, study design, diagnostic criteria for each group, 
reported time point in migraine cycle, total number of 
intervention groups, specific physical examination tests, 
assessment protocol, outcomes of interest, measurement 
properties assessing statistical methods used and results.
Outcomes and priorisation
Although resolution of headache after neck treatment 
has been accepted as a confirmation for CGH diagnosis;4 
a gold standard physical test which could be used at the 
initial assessment for the differential diagnosis of CGH 
and migraine has not been identified so far. Therefore, 
we aim to identify a measure of physical impairment in 
the neck that will allow clinicians to differentially diag-
nosis between these two headache types, although no 
prioritisation can be defined.
Risk of bias
As done in a recent systematic review26 and recommended 
by the Cochrane Handbook for Systematic Reviews of 
Interventions,32 risk of bias will be assessed (except for 
the diagnostic accuracy studies) using the Downs and 
Black Scale,33 but excluding those items that have been 
proposed to assess interventions. Each trial will be inde-
pendently assessed and scored by two reviewers (AS and 
KL) in terms of risk of bias, and a third reviewer (DF) 
will intervene in the case of disagreement. A quality index 
will be calculated, indicating low, moderate or high risk 
of bias. The Cohen kappa coefficient will be calculated 
to express the agreement between reviewers. The same 
procedure, by the same reviewers, will be used to assess 
risk of bias of diagnostic accuracy studies. However, in 
this case, the Quality Assessment of Diagnostic Accuracy 
Studies (QUADAS-2)34 tool will be used, which was devel-
oped to evaluate quality of this type of study, separating 
risk of bias and concerns regarding applicability. Using 
this tool, risk of bias will be judged as ‘low’, ‘high’ or 
‘unclear’.34
data synthesis
If possible, a meta- analysis will be conducted; if not 
possible due to heterogeneity of populations studied, 
a narrative synthesis will be conducted for all included 
studies. This synthesis will include presentation of data 
in a summary and in tables. Synthesis of results will 
follow recommendations from the COSMIN guideline 
for systematic reviews. The quality of the evidence will 
be assessed using the QUADAS-234 scale for the quality 
of diagnostic accuracy studies and the Downs and Black 
Scale33 for the studies where the QUADAS-2 checklist 
cannot be used. The reviewers will agree on which check-
list to use for each study.
Metabiases
In order to determine whether any reporting bias is 
present, a detailed search for unpublished studies will be 
conducted, for example, accessing any past conference 
proceedings in the last 10 years, and internet searches in 
clinical trial registries, with consistency between proto-
cols and published studies examined, if protocols are 
available.
Confidence in cumulative evidence
As this systematic review assess the confidence of physical 
tests, two tools will be used to investigate the strength and 
quality of evidence. The QUADAS-2 scale for diagnostic 
accuracy studies and in those studies where this checklist 
cannot be used, Downs and Black Scale will be applied.
Patient and public involvement
The research question in this study was developed 
following consultation and discussion with headache 
patients. Patients will not be involved in the analysis and 
data collection of the systematic review.
Clinical implications
Headache is a common disorder with a significant impact 
on the quality of life of sufferers.1–3 Due to the large symp-
tomatic overlap between different headache types, differ-
ential diagnosis can be challenging, particularly between 
CGH and migraine12–14 which can lead to an inappro-
priate choice of treatment.
Physical tests have been developed and described to facil-
itate the identification of musculoskeletal impairments 
which could facilitate differential diagnosis between CGH 
and other forms of headache, in order to confirm the 
presence of cervical musculoskeletal dysfunction which 
could be triggering the headache. However, controversy 
remains about the utility of the physical examination to 
differentiate migraine from CGH especially since many 
patients with migraine also suffer from neck pain and 
have shown cervical musculoskeletal impairment in the 
past. This systematic review will determine whether phys-
ical tests can differentiate CGH from migraine and from 
asymptomatic subjects which has direct relevance for 
clinicians managing people with headache.
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